As part of its support for trial preparation, ECRIN offers a unique service called “ECRIN-On-Board” (EoB). The goal is to improve the quality of applications for EU funding through early support on the protocol and the logistical/operational aspects of project design.
Similar to traditional ECRIN support, ECRIN’s Scientific Board provides methodological consulting on the protocol, while ECRIN’s European Correspondents advise on issues such as work package organisation.
EoB At a Glance
What it is: A free advice service provided by ECRIN to help multinational, clinical research projects improve the quality of their applications for multinational funding (e.g., Horizon 2020, E-Rare).
How it works:
- The principal investigator (PI) submits a short study synopsis to the European Correspondent in his/her country (using the EoB study synopsis template)
- ECRIN’s Scientific Board provides methodological consulting
- ECRIN advises on logistical/operational issues and structural components: work package organisation (particularly in regards to clinical trial organisation), regulatory and ethical issues, insurance, contracting, monitoring, costs, risk and mitigation, trial oversight, site identification and selection, governance, consortium composition, management, etc.
Note: ECRIN-On-Board does not draft the actual application.
Timeline: Synopses should be prepared three to six months before the funding application deadline. Support is generally given within four to six weeks based on pre-defined deadlines.
Eligibility: In general, only investigators from ECRIN Member Countries are eligible to use the ECRIN-On-Board service.
Benefits: Investigators benefit from early collaborative involvement of ECRIN in the application process, taking full advantage of ECRIN’s expertise in multinational trial management.
For more information, click on the drop-down menu below.